Ποια είναι η τιμή για Hubei Jumpcan Pharmaceutical Co., Ltd. (600566)

Η τιμή για Hubei Jumpcan Pharmaceutical Co., Ltd. (600566) είναι $3.63

Ποια είναι η κεφαλαιοποίηση αγοράς για Hubei Jumpcan Pharmaceutical Co., Ltd. (600566)

Η κεφαλαιοποίηση αγοράς για Hubei Jumpcan Pharmaceutical Co., Ltd. (600566) είναι $3.34B

Hubei Jumpcan Pharmaceutical Co., Ltd. (600566) Τιμή και Κεφαλαιοποίηση Αγοράς

Hubei Jumpcan Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the full spectrum of pharmaceutical operations, encompassing research, development, production, and marketing. The company's product lines include both traditional Chinese and Western medicines, as well as daily-use chemical products incorporating traditional Chinese medicine, and health supplements rooted in Chinese medical practices. Their diverse range of Chinese and Western pharmaceuticals addresses a wide array of therapeutic areas, such as pediatric care, women's health, respiratory conditions, digestive disorders, and geriatric medicine. Additionally, their development pipeline covers treatments for detoxification, nervous system ailments, anti-infective agents, cardiovascular issues, pain relief, nutritional deficiencies, musculoskeletal problems, and blood clotting management. Beyond medicinal products, Jumpcan also manufactures oral and skin care items. The company's Chinese medicine-based health products are designed to provide benefits like fatigue reduction, anti-aging effects, antioxidant support, and immune system boosting. Headquartered in Taixing, China, the company adopted its current name, Hubei Jumpcan Pharmaceutical Co., Ltd., in March 2015, having previously operated as Hubei Hongcheng General Machinery Co., Ltd.

Η τιμή για 600566	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$5,519.90 $3.34B	NVDA	$5.088T	+152,080.94%
$5,022.17 $3.34B	AAPL	$4.629T	+138,358.68%
$4,467.24 $3.34B	GOOG	$4.118T	+123,059.52%
$3,999.77 $3.34B	MSFT	$3.687T	+110,171.67%
$3,037.37 $3.34B	AMZN	$2.800T	+83,638.94%

Η τιμή για 600566

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$5,519.90 $3.34B